Oncodiag
French tech company | Builders Republic
About
Diagnostics company developing non-invasive urine tests for the early detection and monitoring of urological cancers — its Urodiag test combines genetic and methylation biomarkers to flag bladder-cancer recurrence, helping urologists reduce reliance on invasive cystoscopies.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2013
- City
- EVREUX
- Region
- Normandie
- Tracked rounds
- 1
- Amount raised
- 1.4 M€ raised since 2020
Funding rounds
- Series A — 2025